Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries

Human Mutation
A J BergmanR Berger

Abstract

Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a deficient activity of the enzyme fumarylacetoacetase (FAH). To investigate the molecular heterogeneity of tyrosinemia, the geographic distribution and the genotype-phenotype relationship, we have analyzed the FAH genotype of 25 HT1 patients. Mutation screening was performed by PCR amplification of exons 1-14 of the FAH gene, followed by SSCP analysis and direct sequencing of the amplified exons. Fourteen different mutations were found, of which seven were novel, viz. three missense mutations (G158D, P261L, F405H), a deletion of three nucleotides causing a deletion of serine (DEL366S) and three splice site mutations: IVS2+1(g-t), IVS6-1(g-c), IVS8-1(g-c). The splice site mutations IVS6-1(g-t) and IVS12+5(g-a) were frequently found in countries around the Mediterranean and northwestern Europe, respectively. No clear correlation between the genotype and the three major HT1 subtypes could be established.

References

Nov 1, 1988·Clinical Genetics·N BaşaranJ D Stevenson
Feb 1, 1995·Human Molecular Genetics·M St-LouisR M Tanguay
Nov 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F J van SpronsenH S Heymans
Oct 1, 1994·The Journal of Clinical Investigation·E A KvittingenP Brandtzaeg
Apr 1, 1993·The Journal of Clinical Investigation·E A KvittingenR Berger
Jan 1, 1996·Human Mutation·H RootweltE A Kvittingen
Feb 11, 1997·American Journal of Medical Genetics·J Zlotogora

❮ Previous
Next ❯

Citations

Nov 2, 2004·Human Genetics·T G W LetteboerJ K Ploos van Amstel
Nov 30, 2012·Case Reports in Genetics·Jayesh J ShethFrenny J Sheth
Sep 11, 2013·BMC Research Notes·Sarar MohamedAbdullah S Al-Jarallah
Jul 3, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Hyung-Doo ParkYong-Wha Lee
Feb 24, 2006·Paediatric Drugs·Merja AshornMarkku Heikinheimo
Dec 29, 2000·Annals of Medicine·S T PitkänenM Heikinheimo
Aug 2, 2014·Orphanet Journal of Rare Diseases·Sebene MayorandanAnibh Das
Sep 30, 2006·Molecular Genetics and Metabolism·C J L KoelinkF J van Spronsen
Apr 20, 2016·Fetal and Pediatric Pathology·Maryam RafatiSaeed Reza Ghaffari
Jul 19, 2011·Molecular Genetics and Metabolism·Faiqa ImtiazMoeen Al-Sayed
Oct 3, 2019·Medicine·María Luz CouceCarmen Díaz-Fernández
Feb 11, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·S Harvey Mudd
Jul 15, 2011·Pediatrics International : Official Journal of the Japan Pediatric Society·Maria Luz CouceUNKNOWN Spanish Working Group on Tyrosinemia type 1
May 24, 2001·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·P A RussoR M Tanguay
Oct 12, 2021·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Eric T RushKathryn Dahir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.